Barclays Reiterates Overweight Rating on Twist Bioscience Corporation (TWST)
Rating Change Barclays analysts reiterated a Overweight rating on Twist Bioscience Corporation (NASDAQ:TWST) on June 24, 2026. Market Context Twist Bioscience Corporation operates…
Read more
